Home/Filings/4/0001615219-22-000142
4//SEC Filing

Arthur David J. 4

Accession 0001615219-22-000142

CIK 0001615219other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 4:34 PM ET

Size

6.3 KB

Accession

0001615219-22-000142

Insider Transaction Report

Form 4
Period: 2022-11-03
Arthur David J.
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2022-11-03$1.73/sh+10,000$17,340285,674 total
Holdings
  • Common Stock

    (indirect: By son)
    14,100
  • Common Stock

    (indirect: By daughter)
    13,800
Footnotes (1)
  • [F1]These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001769331

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:34 PM ET
Size
6.3 KB